Gang Chen

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-2378-6056

发表论文 79 篇 · 总被引 1924 次 · h-index 19

代表论文

• BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study (2024 · The Lancet Oncology · 被引 151)
• AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial (2023 · EClinicalMedicine · 被引 109)
• Amygdala Functional Connectivity Features in Grief: A Pilot Longitudinal Study (2020 · American Journal of Geriatric Psychiatry · 被引 39)
• Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment (2025 · International Journal of Nanomedicine · 被引 36)
• Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial (2025 · Journal of Hematology & Oncology · 被引 31)
• QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study (2024 · Signal Transduction and Targeted Therapy · 被引 25)